Multicenter phase II study of oral capecitabine plus irinotecan as first-line chemotherapy in advanced colorectal cancer: A Korean Cancer Study Group Trial

Phase Ii Study ◽

Study Group ◽

First Line ◽

Oral Capecitabine ◽

Multicenter Phase ◽

Cancer Study Group ◽

Group Trial ◽

Phase II study of Ccr-based dose-control of S-1 in the first-line chemotherapy of S-1/oxaliplatin (SOX) + bevacizumab regimen for advanced colorectal cancer

Annals of Oncology ◽

10.1093/annonc/mdx393.139 ◽

2017 ◽

Vol 28 ◽

pp. v208

Author(s):

D. Manaka ◽

R. Nishitai ◽

S. Konishi ◽

T. Ohta ◽

T. Hattori ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

First Line ◽

Dose Control ◽

Bevacizumab + folfiri as first-line treatment in advanced colorectal cancer (ACC): A multicenter phase II study of the Gruppo Oncologico dell'Italia Meridionale (prot. GOIM 2601)

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.15048 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 15048-15048

Author(s):

G. Colucci ◽

F. Giuliani ◽

V. Lorusso ◽

F. De Vita ◽

S. Cinieri ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Multicenter Phase ◽

First Line Treatment

Phase III study comparing vinorelbine/gemcitabine with vinorelbine/carboplatin as first-line chemotherapy of advanced NSCLC: A Norwegian Lung Cancer Study Group trial.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7597 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7597-7597 ◽

Cited By ~ 1

Author(s):

Ø. Fløtten ◽

R. M. Bremnes ◽

B. H. Grønberg ◽

S. Sundstrøm ◽

T. Amundsen ◽

...

Keyword(s):

Lung Cancer ◽

Advanced Nsclc ◽

Phase Iii ◽

Study Group ◽

First Line ◽

Cancer Study Group ◽

Lung Cancer Study Group ◽

Phase Iii Study ◽

Group Trial ◽

Predictive and prognostic value of microsatellite instability in patients with advanced colorectal cancer treated with a fluoropyrimidine and oxaliplatin containing first-line chemotherapy. A report of the AIO Colorectal Study Group

International Journal of Colorectal Disease ◽

10.1007/s00384-008-0504-2 ◽

2008 ◽

Vol 23 (11) ◽

pp. 1033-1039 ◽

Cited By ~ 50

Author(s):

C. I. Müller ◽

K. Schulmann ◽

A. Reinacher-Schick ◽

N. Andre ◽

D. Arnold ◽

...

Keyword(s):

Colorectal Cancer ◽

Microsatellite Instability ◽

Prognostic Value ◽

Study Group ◽

First Line ◽

Predictive And Prognostic Value ◽

Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-006-0302-x ◽

2006 ◽

Vol 59 (5) ◽

pp. 613-620 ◽

Cited By ~ 14

Author(s):

Daniele Santini ◽

Bruno Vincenzi ◽

Gaia Schiavon ◽

Marisa Di Seri ◽

Vladimir Virzí ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

First Line ◽

Colorectal Cancer Patients ◽

Phase II Study of Oral S-1 Plus Irinotecan in Patients with Advanced Colorectal Cancer: Hokkaido Gastrointestinal Cancer Study Group HGCSG0302

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyi025 ◽

2005 ◽

Vol 35 (2) ◽

pp. 88-89 ◽

Cited By ~ 4

Author(s):

Y. Komatsu

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Gastrointestinal Cancer ◽

Phase Ii Study ◽

Study Group ◽

Cancer Study ◽

Cancer Study Group

A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancer

Clinical & Translational Oncology ◽

10.1007/s12094-012-0843-x ◽

2012 ◽

Vol 14 (8) ◽

pp. 606-612 ◽

Cited By ~ 13

Author(s):

Cristina Gravalos ◽

Antonieta Salut ◽

Carlos García-Girón ◽

Rocío García-Carbonero ◽

Ana Isabel León ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

First Line ◽

Randomized Phase Ii ◽

Bevacizumab+folfiri as first-line treatment in advanced colorectal cancer (ACC): A multicenter phase II study of the Gruppo Oncologico dell’ Italia Meridionale (prot. GOIM 2601)

European Journal of Cancer Supplements ◽

10.1016/j.ejcsup.2008.06.042 ◽

2008 ◽

Vol 6 (14) ◽

pp. 121

Author(s):

F. Giuliani ◽

V. Lorusso ◽

F. De Vita ◽

S. Cinieri ◽

E. Maiello ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Multicenter Phase ◽

First Line Treatment

Abstract P3-11-07: Exploratory biomarker analysis from a phase II, multicenter, randomized trial of eribulin plus gemcitabine(EG) versus paclitaxel plus gemcitabine(PG) as first-line chemotherapy for human epidermal growth factor receptor 2 (HER2)- negative metastatic breast cancer(MBC): Korean cancer study group trial (KCSG BR13-11)

10.1158/1538-7445.sabcs18-p3-11-07 ◽

2019 ◽

Author(s):

J-Y Kim ◽

EJ Lee ◽

KH Park ◽

S-A Im ◽

S-B Kim ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Study Group ◽

First Line ◽

Cancer Study Group ◽

Biomarker Analysis ◽

Epidermal Growth ◽

Group Trial ◽

Voice Trial-Results from a Multicenter Phase Ii Study of Assessment of Clinical Efficacy and Safety in Capecitabine Plus Intermittent Oxaliplatin Together with Bevacizumab As the First-Line Therapy for the Patients with Advanced Colorectal Cancer

Annals of Oncology ◽

10.1093/annonc/mdu333.27 ◽

2014 ◽

Vol 25 ◽

pp. iv178

Author(s):

C. Kosugi ◽

K. Koda ◽

T. Denda ◽

K. Ishibashi ◽

H. Ishida ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Clinical Efficacy ◽

Phase Ii Study ◽

Efficacy And Safety ◽

First Line ◽

First Line Therapy ◽

Multicenter Phase ◽

Line Therapy